KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Current Assets (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Current Assets data on record, last reported at $5.1 billion in Q4 2025.

  • For Q4 2025, Current Assets rose 9.6% year-over-year to $5.1 billion; the TTM value through Dec 2025 reached $5.1 billion, up 9.6%, while the annual FY2025 figure was $5.1 billion, 9.6% up from the prior year.
  • Current Assets reached $5.1 billion in Q4 2025 per ZBH's latest filing, down from $5.8 billion in the prior quarter.
  • Across five years, Current Assets topped out at $5.8 billion in Q3 2025 and bottomed at $4.4 billion in Q3 2023.
  • Average Current Assets over 5 years is $4.8 billion, with a median of $4.7 billion recorded in 2024.
  • Peak YoY movement for Current Assets: decreased 21.52% in 2021, then rose 20.7% in 2025.
  • A 5-year view of Current Assets shows it stood at $4.9 billion in 2021, then decreased by 9.37% to $4.4 billion in 2022, then rose by 4.12% to $4.6 billion in 2023, then grew by 1.35% to $4.7 billion in 2024, then grew by 9.6% to $5.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $5.1 billion in Q4 2025, $5.8 billion in Q3 2025, and $5.1 billion in Q2 2025.